CCOc1cc(-c2sc(Nc3cc(C)ccc3OC)n[n+]2-c2ccccc2)ccc1OC.[Cl-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?